poisar

Stocks · News reference

Milestone Pharmaceuticals Q2 EPS $(0.21) Misses $(0.20) Estimate, Sales $559.000K Miss $816.667K Estimate

Aug 12, 2026, 11:02 AMBenzinga Newsdesk

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.20) by 10.53 percent. This is a 5 percent decrease over losses of $(0.20) per

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

MIST
Source
benzinga
Observed
Aug 12, 2026, 11:02 AM
Checked
Aug 12, 2026, 11:02 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading